课题基金 / 基金详情

项目摘要

项目成果

Mikhael Shor的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Americans have many alternatives among health and drug coverage plans. This is particularly true for Medicare Part D drug coverage plans. Increased choice usually correlates with a greater chance that an available option will best meet the particular needs of an individual, but an abundance of options may cause confusion and lead to selection errors. The aim of this project is to better understand why individuals often make poor choices when faced with complex decisions, and to suggest guidelines and selection interface designs that improve individuals' decision-making performance. Our experimental approach is to quantify the frequency and magnitude of selection errors when individuals are asked to choose the optimal plan from among a set of competing plans. This decision closely mimics the task of choosing among drug plans that include coverage for some drugs but not others, but also applies generally to other health plan selection choices. The proposed experiment interface will present each subject with a series of matrices each showing the attributes (analogous to the set of covered and not covered drugs) of each selection option (i.e., all available Part D drug plans). Experimental subjects will be asked to select the best plan from among the available options, and will be financially compensated in proportion to the accuracy of their selections. We will systematically examine how subjects' decisions are affected by the complexity of the problems they are facing. Also, variations in the experimental interface will test competing behavioral theories about how people process information and make complex choices, leading the development of a decision-making model against which improved formats can be tested. Central to the experimental design will be a careful investigation of decision-making acumen as a function of demographic factors including education level, sex, and especially age (preliminary work has demonstrated seniors under-perform substantially in complex settings). Subjects will be recruited via in-person visits to seniors' facilities and electronically from among a very large demographically-diverse on-line experimental economics subject pool. Differences among the subject pools and the effect of compensation amount on subject performance will be measured. Project outcomes will include recommendations to policy-makers on structuring complex choices to minimize selection errors. As a result, under-performing groups could be enabled to make better choices about health insurance and drug coverage, improving health outcomes of seniors. Project Narrative: The goal of this project is to further our understanding of the potential for error when people encounter complex decisions, as in the selection of health care and drug coverage plans. This study will examine underlying differences in decision-making acumen between the general population and more poorly performing sub-groups, possibly relating to education level, sex, and especially age. Study outcomes will include recommendations for restructuring decision sets to enable under-performing groups, especially seniors, to make better long-term choices improving their own health outcomes.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.socec.2013.08.007
发表时间: 2013-12-01
期刊: JOURNAL OF SOCIO-ECONOMICS
影响因子: --
作者: [Deck, Cary, Kimbrough, Erik O.]
通讯作者: Kimbrough, Erik O.
Decision-making Strategies and Performance among Seniors.
老年人的决策策略和绩效。
DOI: 10.1016/j.jebo.2011.07.016
发表时间: 2012
期刊: Journal of economic behavior & organization
影响因子: 2.2
作者: [Besedeš,Tibor, Deck,Cary, Sarangi,Sudipta, Shor,Mikhael]
通讯作者: Shor,Mikhael
Confusion from Profusion: Decision Making with Many Options
  • 批准号:
    7388683
  • 项目类别:
  • 资助金额:
    $21.61万
  • 财政年份:
    2008
  • 负责人:
    Mikhael Shor
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: